Literature DB >> 35845158

Transplant-associated thrombotic microangiopathy: a rare but deadly complication post orthotopic heart transplantation.

Jose Ruiz-Morales1, Maedeh Ganji2, Rohan Goswami1.   

Abstract

Entities:  

Year:  2022        PMID： 35845158      PMCID： PMC9248271          DOI： 10.11909/j.issn.1671-5411.2022.06.008

Source DB:  PubMed          Journal:  J Geriatr Cardiol        ISSN： 1671-5411            Impact factor:   3.189


× No keyword cloud information.
  5 in total

Review 1.  Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.

Authors:  Kiarash Kojouri; James N George
Journal:  Curr Opin Oncol       Date:  2007-03       Impact factor: 3.645

Review 2.  Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.

Authors:  C John Sperati; Alison R Moliterno
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

3.  Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients.

Authors:  Joslyn Rudoni; Anna Jan; Chitra Hosing; Fleur Aung; Jason Yeh
Journal:  Eur J Haematol       Date:  2018-07-27       Impact factor: 2.997

4.  Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy.

Authors:  Eleni Gavriilaki; Akrivi Chrysanthopoulou; Ioanna Sakellari; Ioannis Batsis; Despina Mallouri; Tasoula Touloumenidou; Apostolia Papalexandri; Alexandros Mitsios; Athanasios Arampatzioglou; Konstantinos Ritis; Robert Alan Brodsky; Ioannis Mitroulis; Achilles Anagnostopoulos
Journal:  Thromb Haemost       Date:  2019-07-02       Impact factor: 5.249

Review 5.  Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.

Authors:  James N George; Xiaoning Li; Jay R McMinn; Deirdra R Terrell; Sara K Vesely; George B Selby
Journal:  Transfusion       Date:  2004-02       Impact factor: 3.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.